Tuberculosis / Projects

3rd Health Programme (2014-2020)
Strengthening the role of civil society within the TB response in Europe [TBEC]
The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the...
The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the role of civil society within the regional response to tuberculosis (TB), and to increase the political and financial commitment required to effectively control the epidemic in region. TBEC was formed by a group of TB advocates in 2009. They identified a need to capacitate and bring together civil society in order to address two major concerns: high-rates of drug resistance, coupled with low awareness among general populations and policy-makers about this problem. This was especially due to a scarcity of civil society stakeholders working on TB in the region, despite their important role within an effective response, with few capable of advocating for TB at national or regional level. TBEC addresses this by providing a coordinating body that brings together civil society stakeholders across the region, disseminates high-quality information and resources, promotes collaboration and best practice, and aims to build the advocacy capacity of civil society stakeholders working to control TB.
Start date: 01/01/2015 - End date: 31/12/2015

Call: Specific Grant Agreements for 2015 under the Framework Partnership Agreement for Operating Grants 2015-2017
Topic: Tuberculosis
3rd Health Programme (2014-2020)
EPHA Operating Grant Proposal 2016 SGA [EPHA SGA 2016]
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four o...
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four objectives of the Third Health Programme. EPHA has formally reviewed our Strategic Plan 2011-2015. We undertook a thorough consultation process involving Board members, Staff and the EPHA membership, and an analysis of EPHA’s operating environment, strengths and weaknesses. The EPHA membership formally approved the new Strategic Plan 2016-2020 at the Annual General Assembly on 4th September 2015. The Work Programme for 2016 reflects the revised strategy to define a clearer selection of priorities. This approach will enable EPHA to manage activities more effectively, encourage closer cooperation between members and across themes, and better monitor and evaluate our impact.EPHA’s overarching strategic objective remains: “To promote good health and wellbeing, to reduce disease and health inequalities in European policies and programmes”. Priorities selected are as follows:Under Aims 1 and 2 of the 3rdHP and EPHA Strategic Objective “Securing a Governance for Health Approach in Key EU Policies” (HiAP):- Agriculture and Food Policy including Alcohol, Tobacco and NCDs- EU Semester for Health- Healthy Trade Policy- Public Health and Research in the EU BudgetUnder Aims 3 and 4 of the 3rdHP and EPHA Strategic Objective “Strengthen EU Policies to Reduce Health Inequalities and Ensure Universal Access to Sustainable, Inclusive Health Systems”:- Universal and Fair Access to Medicines- Action on Antimicrobial Resistance- Inclusive E- and M-Health- HSPAEach of these areas has operational objectives, milestones, deliverables and impact indicators. The Work Programme 2016 also highlights organisational development objectives, particularly on cooperation with academia, communications and financial sustainability, which are priorities for 2016.
Start date: 01/01/2016 - End date: 31/12/2016
Keywords : [ Amr ] [ Anthrax ] [ Anthrax ] [ Blood ] [ Botulism ] [ Breast ] [ Brucellosis ] [ Campylobacteriosis ] [ Cancer ] [ Cardiovascular Diseases ] [ Cervical ] [ Chlamydia ] [ Cholera ] [ Chronic Diseases ] [ Chronic Diseases ] [ Chronic kidney diseases ] [ Chronic pulmonary diseases ] [ Colorectal ] [ Communicable Diseases ] [ Communicable Diseases ] [ Cryptosporidiosis ] [ Dengue fever ] [ Diabetes ] [ Diphtheria ] [ Diseases of zoonotic and environmental origin and vector borne ] [ E/M-Health ] [ Echinococcosis ] [ Economic Policy ] [ Emergent pathogens ] [ Epilepsy ] [ Food and waterborne diseases ] [ Giardisasis ] [ Gonorrhea ] [ HIV, STIs & Blood borne infections ] [ Health Research ] [ Healthcare-associated infections ] [ Hepatitis A ] [ Hepatitis B ] [ Hepatitis C ] [ Hiap ] [ Hiv/Aids ] [ Hpv ] [ Hspa. ] [ Influenza ] [ Invasive Haemophilus influenzae disease ] [ Invasive pneumococcal disease ] [ Ischaemic heart disease ] [ Legionnaire's diseaese ] [ Leptospirosis ] [ Leptospirosis ] [ Listeriosis ] [ Lung ] [ Malaria ] [ Measles ] [ Menongoccal disease ] [ Multiple sclerosis ] [ Mumps ] [ Musculo skeletal conditions ] [ Ncds ] [ Neurological diseases and disorders ] [ Other specific diseases ] [ Parkinson's disease ] [ Participation ] [ Plague ] [ Polio ] [ Prevention ] [ Prevention ] [ Promotion ] [ Protection ] [ Public Health ] [ Qfever ] [ Rabies ] [ Respiratory tract infections ] [ Rubella ] [ SARS ] [ Salmonellosis ] [ Shigellosis ] [ Shigellosis ] [ Smallpox ] [ Stomach ] [ Stroke ] [ Syphilis ] [ Tetanus ] [ Toxoplasmosis ] [ Trade ] [ Trichinellosis ] [ Tuberculosis ] [ Tularaemia ] [ Tularemia ] [ Type I ] [ Typhoid fever ] [ Universal Access ] [ VTEC ] [ Vaccine-preventable diseases ] [ Variant Creutzfeld-Jakob disease ] [ Viral Haemorrhagic fevers ] [ West Nile fever ] [ Yellow fever ] [ Yersiniosis ] [ campylobacteriosis ] [ pertussis ] [ prostate ] [ salmonellosis ] [ skin ] [ type II ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries
Topic: Tuberculosis
3rd Health Programme (2014-2020)
Strengthening the role of civil society within the TB response in Europe [TBEC]
The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the...
The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the role of civil society within the region response to tuberculosis (TB), and to increase the political and financial commitment required to effectively control the epidemic in the region.
The year 2016 is another critical year for the fight against tuberculosis (TB) in Europe. The latest evidence continues to affirm that the fight against TB, and particularly drug-resistant TB, is far from won in the region and sustained community advocacy, capacity building, and high-level advocacy are needed to achieve this goal.

Main specific objectives of the programme:
1) Increase understanding of the civil society contribution to the TB response;
2) By the end of 2016, maintain and strengthen the TBEC website as a regional platform serving 375 civil society stakeholders working within the TB response;
3) Provide access to TBEC support and representation to civil society stakeholders in at least 75% of countries within the Region by the end of 2016;
4) Strengthen the voice of civil society in all accessible EU and regional forums/ consultations throughout 2016;
5) Manage TBEC’s governance and internal processes for the successfully implementation of this work programme throughout 2016;

These objectives will be achieved via the delivery of key outputs:
- Map civil society stakeholders across the WHO European Region
- Facilitate access to information and resources for capacity building for target groups
- Conduct outreach to civil society across the region with the aim of expanding the network and building relationships with target groups
- Engage with decision-makers on behalf of civil society across the region
- Manage the network effectively to implement the three-year work programme





Start date: 01/01/2016 - End date: 31/12/2016

Call: Health Programme Adhoc Call for invited (named) beneficiaries
Topic: Tuberculosis
3rd Health Programme (2014-2020)
Strengthening the role of civil society within the TB response in Europe [TBEC]
The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the...
The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the role of civil society within the region response to tuberculosis (TB), and to increase the political and financial commitment required to effectively control the epidemic in the region.
The year 2017 is the 3rd year of the FPA and another critical year for the fight against tuberculosis (TB) in Europe. The latest evidence continues to affirm that the fight against TB, and particularly drug-resistant TB, is far from won in the region and sustained community advocacy, capacity building, and high-level advocacy are needed to achieve this goal.

Main specific objectives of the programme:
1) Increase understanding of the civil society contribution to TB response across 80% of the Region by the end of 2017;
2) By the end of 2017, maintain and strengthen the TBEC website as a regional platform serving 400 civil society stakeholders working within the TB response;
3) Provide access to TBEC support and representation to civil society stakeholders in at least 80% of countries within the Region by the end of 2017;
4) Strengthen the voice of civil society in all accessible EU, regional and international forums/consultations throughout 2017;
5) Manage TBEC’s governance and internal processes for the successful implementation of this work programme throughout 2017.

These objectives will be achieved via the delivery of key outputs:
- Mapping civil society stakeholders across the region;
- Facilitate access to information and resources for target groups;
- Conduct outreach to civil society across the region with the aim of expanding the network and building relationships with target groups;
- Engage with decision-makers to advocate on behalf of civil society across the region;
- Manage the network effectively to implement the three-year work programme.

Start date: 01/01/2017 - End date: 31/12/2017

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)
Topic: Tuberculosis
3rd Health Programme (2014-2020)
Joint Action on HIV and Co-infection Prevention and Harm Reduction [HA-REACT]
The Joint Action proposal on “HIV and Co-infection Prevention and Harm Reduction” (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections (especially tuberculosis and h...
The Joint Action proposal on “HIV and Co-infection Prevention and Harm Reduction” (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections (especially tuberculosis and hepatitis) in priority areas of the EU. Despite huge advances in treatment and care and successful implementation of evidence-based preventive interventions in many EU member states, these infections are still not controlled among certain population groups and regions. The HA-REACT Joint action (JA) directly addresses the Communication from the Commission [COM(2009)569] on “Combating HIV/AIDS in the European Union and neighbouring countries, 2009 -2013” and relevant actions laid out in the associated [SWD(2014)106] action plan extension 2014-2016. The project takes a practical rather than a theoretical or purely guiding approach. It will implement concerted, multi-country, and multi-actor actions, strengthening evidence-based practices in the focus countries, where the situation and needs are particularly challenging. Focused action for greater impact is the leading principle of this proposal. The HA-REACT will focus on pragmatic actions targeting the most vulnerable populations, i.e. people who inject drugs (PWID). The focus countries for the JA were selected according to an objective and transparent selection criteria, developed by the ECDC and the EMCDDA in which the countries were ranked according to their epidemic situation and coverage of preventive measures. In addition to work packages of Coordination, Dissemination and Evaluation, HA-REACT actions are organized into five core work packages: Testing and linkage to care, Scaling up harm reduction, Harm reduction and continuity of care in prisons, Integrated care, Sustainability and long-term funding.
Start date: 01/10/2015 - End date: 31/01/2019

Call: Grants for actions co-financed with Member State authorities 2014 (Joint Actions)
Topic: Tuberculosis